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Background: Many studies have reported that hypertension is common in chronic daily headache (CDH) and its
subtype chronic migraine (CM), but the reason is still poorly understood. Our clinical literature review suggested
that analgesic overuse may be associated with elevated blood pressure (BP), so we performed the present study to
investigate the frequency of elevated BP and its link with analgesic overuse in CDH and its subtypes.
Methods: A cross-sectional study was conducted in neurology outpatients with a diagnosis of CDH according to
International Headache Society criteria. CDH patients were classified into CM and non-CM groups, and subclassified
with or without analgesic overuse.
Results: Elevated BP was present in 27.96% of CDH patients. Compared with non-CM patients, patients with CM
had a longer duration of headache and more severe pain intensity, and a family history of headache and analgesic
overuse were also more common, but the elevated BP frequency was not different between the two groups.
Almost one-third of the patients had analgesic overuse; 96.8% of which comprised acetaminophen-containing
agents. Those with analgesic overuse had a higher frequency of headache than those without analgesic overuse in
both the CM and non-CM groups.
Conclusions: Although the CM patients had a longer duration of headache, more severe intensity, the frequency of
elevated BP wasn’t higher than non-CM group. Analgesic overuses maybe the reason of higher frequency of
elevated BP in CDH and its subtypes. This may have predictive value for clinicians to improve CDH management.
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CDH has a worldwide prevalence of 3% in the general
population and is one of the most frequent consultation
syndromes at headache clinics [1,2]. CDH lays a heavy
burden on individuals and society, because of its
frequency, severity and reduced quality of life. There is a
relationship between hypertension and CDH and its sub-
type CM [3-5], which suggests that prevalence of hyper-
tension is significantly higher in CDH or CM than in
other headache groups.* Correspondence: zjyheadache@hospital-cqmu.com
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in any medium, provided the original work is pCM is the most common subtype of CDH [6-9], Mathew
et al. reported that patients with CDH transformed from
originally episodic migraine had a higher possibility of
hypertension [10], but the reason was poorly understood.
Analgesic overuse is frequently identified as the most im-
portant risk factor for CM [11]. In CDH subtypes, CM pa-
tients are more likely to have analgesic overuse, which is a
significant predictor of poor outcome.
Acetaminophen-containing agents are common in
Chinese patients with analgesic overuse. In our previous
study, 91.1% of patients with analgesic overuse used
combination analgesics, in which acetaminophen and as-
pirin were the major components; 8.9% used nonsteroi-
dal anti-inflammatory drugs (NSAIDs); and none used
triptans or ergot alkaloids [12]. Acetaminophen is ann Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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line therapy for the management of chronic pain because
of its greater cardiovascular safety and its low cost. Our
review of the clinical literature suggested that acet-
aminophen is linked with a higher incidence of hyper-
tension [13,14]. Treatment with acetaminophen results
in a significant increase in mean systolic ambulatory BP
in patients with coronary artery disease [15]. Aspirin
dose is not significantly associated with hypertension
[16,17]. Low-dose aspirin (75–325 mg/day) use is associ-
ated with a significant reduction in the risk of cardiovas-
cular events [18,19].
There is no consensus about whether there is any differ-
ence in the frequency of hypertension in patients with
CDH with or without analgesic overuse. One study found
that the prevalence of hypertension in CDH did not sig-
nificantly between with and without analgesic overuse [3].
However, another study reported that both CM with or
without analgesic overuse had a stronger association with
hypertension compared with other types of chronic head-
ache (e.g. chronic post-traumatic headache) [5].
We performed the present study to investigate the dif-
ference in frequency of elevated BP in CM compared
with other types of chronic headache; we also aimed to
establish whether long-term use of acute analgesics
increased BP in CDH patients and its subtypes, to pro-
vide effective strategies for the management of CDH and
its subtypes.
Methods
Patient selection and study design
This was a cross-sectional study conducted at the
Neurological Outpatient Department of the First Affiliated
Hospital of Chongqing Medical University, China. All pa-
tients at least 18 years who consulted neurologists with a
chief complaint of headache were included if they fulfilled
the following criteria: daily or near-daily headache lasting
>4 hours if not treated; occurring >15 days/month; fulfilling
the Proposed Headache Classification for Chronic Daily
Headache described by Silberstein and Lipton [20-22].
The Silberstein and Lipton criteria divide CDH into
four subtypes: chronic or transformed migraine; chronic
tension-type headache; new daily persistent headache;
and hemicrania continua. These are then subclassified as
with or without analgesic overuse.
To be classified as CM, the patients should satisfy the
following conditions: Headache on ≥15 days/month for
at least 3 months, Occurring in a patient who has at
least 8 days/month fulfilling criteria 1.1 (migraine with-
out aura), not attributed to another causative disorder.
Another three subtypes of CDH were classified as non-
CM in order to investigate differences in frequency of
elevated BP in CM compared with other chronic head-
ache types.The diagnosis of analgesic overuse adopted the criteria
proposed by Silberstein and Lipton. Patients who met
the following criteria for at least 3 months in the previous
year were considered to have analgesic overuse: intake of
simple analgesics ≥15 days/month or combination medi-
cations ≥10 days/month for at least 3 months.
A face-to-face interview method was used for data col-
lection. Each participant was examined and given a de-
tailed structured self-administered questionnaire by a
neurologist [12,23-25]. The questionnaire included the
following components: demographic characteristics, clin-
ical features of headache (onset age, duration, frequency,
intensity, location, accompanying symptoms, and aggra-
vation after activity); history of head injury; past medical
history and drug intake for headache; family history of
headache and history of cerebrovascular comorbidity in
first-degree relatives. All patients were asked the above
questions according to the questionnaire.
Headache intensity was evaluated using a 0–10 visual
analog scale (0: no pain; 1–3: mild; 4–6: moderate; 7–9:
severe; 10: maximal pain). BP was measured according to
a standardized method as in other cross-sectional studies
[26,27]. The participants were seated, and BP was mea-
sured 3 times after at least 5 minutes rest, and the average
value was recorded. Elevated BP was diagnosed in patients
with systolic BP (SBP) ≥140 mmHg or diastolic BP (DBP)
≥90 mmHg, or use of antihypertensive agents.
Second headache was excluded using appropriate tests
if necessary. Headache attributed to the use of acute
medication for other conditions was also excluded. The
neurologists were blinded to patient identity when
collecting information about demographic characteris-
tics, headache, and neurological examination.
The study protocol was approved by the Ethical
Committee of the First Affiliated Hospital of Chongqing
Medical University. Informed consent was given by the
patients who agreed to participate in the study.
Statistical analysis
Statistical analysis was performed using SPSS version
17.0. The characteristics of the study population were
analyzed using descriptive statistics. Measurement data
variables were expressed as mean ±standard deviation
(SD). The χ2 and t tests were used for comparison when
appropriate. The aim of collecting information of the
onset age of headache, intensity, accompanying symp-
toms and whether the headache aggravated after activity
was to diagnose, so these were not included in the
analyses. P < 0.05 was considered statistically significant,
and all statistical tests were two-sided.
Results
During the study period (20 July 2011 to 30 December
2011), 10 315 consecutive patients visited the neurological
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Medical University. Among the 1327 patients (12.9%) who
cited headache as their chief complaint, 1219 were able to
participate in the study (response rate 91.9%). Among the
311 patients who suffered from CDH, 6 were excluded be-
cause of incomplete information, and 1 for overuse of ad-
dictive drugs. Finally, a total of 304 CDH patients were
recruited: 109 with CM (53 with and 56 without analgesic
overuse), and 195 non-CM (42 with and 153 without anal-
gesic overuse).
Table 1 summarizes the demographics of the study
population. Women accounts for 75% in CDH patients,
more common in CM group than in non-CM group
(84.2% in CM vs69.4% in non-CM, p=0.004). Compared
with non-CM group, CM patients had a longer duration
of headache than non-CM patients (P < 0.000); pain in-
tensity was more severe,more patients had a family
history of headache; and more were more likely to have
analgesic overuse,although the average number of head-
ache days per month was higher in non-CM than in CM
patients.
With regard to the elevated BP frequency, BMI, the
frequency of low education level, family cerebrovascular
disease history (first degree relative), and smoking andTable 1 The demographics of the study population
Variable C
Age (Y) (mean±SD) 4
Female (n, %) 9
Female to male ratio 5
BMI (mean±SD) 2
Education level (n, %)
Primary school or Less 8
High school or technical school 1
University 9
Elevated Blood Pressure (n, %) 3
DBP 7
BP 1
Smoking (n, %) 1
Alcohol consumption (n, %) 3
Duration of headache history (y, mean±SD) 1
pain intensity (mean±SD) 6
Average headache days per month (day, mean±SD) 2
Average days per month had analgesic overuse 1
Analgesic overuse (n, %) 5
Family headache history (n, %) 5
Cerebrovascular disease history (first degree relative) (n, %) 1
Alcohol consumption and smoking indicated daily or nearly-daily drinking or smoki
first degree relative headache and cerebrovascular disease history; cerebrovascular
ischemic attack (TIA) et al. measurement data variables were expressed as mean±SD
Index. P values were two tailed and p value <0.05 was defined as statistical significaalcohol consumption, there were no significant differ-
ences between the two groups (P > 0.05).
Many modifiable factors influenced CDH progression
and development of CM, analgesic overuse was fre-
quently identified as the most important factor, and was
seen in 95 (31.3%) of CDH patients (Table 2). We ana-
lyzed the effect of analgesic overuse on CM and other
CDH types (as showed in Table 3). In the CM group,
there was no significant difference in age, sex, BMI, fre-
quency of low education level, and smoking between pa-
tients with or without analgesic overuse (P > 0.05).
However, those with analgesic overuse had a longer dur-
ation of headache and more severe pain intensity than
those without analgesic overuse. The frequency of ele-
vated BP was also higher in patients with analgesic over-
use than in those without analgesic overuse (P = 0.011).
Among 85 patients with CDH and elevated BP, 19 were
taking antihypertensive agents, and the mean BP was
126.63/81.05 mmHg. Although both DBP and SBP were
higher in those with analgesic overuse, only SBP was sig-
nificantly higher (P = 0.04).
In the non-CM group, patients with analgesic overuse
were significantly older than those without analgesic


















3(48.6) 42 (21.5) 0.000
8(51.3) 54(27.8) 0.000
4(12.4) 14(7.2) 0.129
ng;Family headache history and Cerebrovascular disease history indicated the
disease included stroke (cerebral hemorrhage, infarction) and transient
; CDH—chronic daily headache; SD—standard deviation;BMI—Body Mass
nce.
Table 2 The occurrence of analgesic overuse in CM and
non-CM patients
CM (n, %) Non-CM (n, %) Total (n, %) P value
Analgesic overuse
Yes 53 (48.6) 42 (21.5) 95 (31.25) 0.000*
No 56 (51.4) 153 (78.5) 209 (68.75)
Total 109 195 304
*p value -the occurrence of analgesic overuse in CM group compared with in
non-CM, p<0.05 had a statistic difference.
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headache character, and history of cerebrovascular
disease in first-degree relatives (P > 0.05). Similar to CM
patients, non-CM with analgesic overuse had a higher
frequency of elevated BP compared with those without
analgesic overuse (P = 0.033).
In the 95 CDH patients with analgesic overuse, 92
were taking compound analgesics or had compound and
simple analgesics together; 3 used one simple analgesic
(ibuprofen or naproxen), in total, 7 patients had NSAIDs
(ibuprofen or naproxen). The most frequently taken
agents included “anti-headache flour”, coldrex, acet-
aminophen and “pain relieved pill”. Except for ibuprofen
and naproxen (NSAIDs), all contained acetaminophen
or both aspirin and acetaminophen contained.Table 3 The demographics of the subgroups of two groups
Variable CM (
Analgesic overuse witho
Age (Y) (mean±SD) 44.66
Female (n, %) 47(79
Female to male ratio 3.92
BMI(mean±SD) 22.71
Education level (n,%)
Primary school or Less 42(71
High school or technical school 10 (1
University or above 7(11.9
EBP frequency (n,%) 10(17
DBP 73.23
SBP 111.7
Smoking (n, %) 8(13.6
Alcohol consumption (n, %) 2(3.4)
Duration of headache history (y, mean±SD) 9.57±
headache frequency/month in the recent 3 months (day, mean±SD) 23.25
Headache pain intensity (mean±SD) 6.21±
Family headache history (n, %) 28(47
Cerebrovascular disease history (first degree relative) (n,%) 10(16
Analgesic overuse indicated compound analgesic >10 days per month or simple an
headache history and Cerebrovascular disease history indicated the first degree rela
included stroke (cerebral hemorrhage, infarction) and transient ischemic attack (TIA
value <0.05. CDH—chronic daily headache; RR(95%CI)—relative risk(95% confidenceTable 4 showed the odds ratio and P value of the risk
of elevated BP frequency in CDH and its subtypes with
analgesic overuse compared with those without analgesic
overuse. For all CDH patients, those with analgesic over-
use had a higher frequency of elevated BP than those
without analgesic overuse (P = 0.001). The risk of ele-
vated BP in CDH with analgesic overuse was 2.468 times
higher than in those without analgesic overuse (OR =
2.468, 95% CI = 1.46–4.17). In CM patients with anal-
gesic overuse, the risk of elevated BP was 3.265 times
higher than in those without analgesic overuse (OR =
3.265, 95% CI = 1.36–7.83). In the non-CM group, the
OR was 2.21 (95% CI = 1.075–4.543).
Discussion
The relationship between headache and hypertension is
still controversial [5,11,27-31]. Some studies in patients
with mild hypertension reported that there was no asso-
ciation between the occurrence of headache and BP vari-
ation [28], and most individuals with headache had BP
similar to those who did not [29]. However, other studies
had the opposite view. Cooper et al. suggested that head-
ache was common in mild to moderate hypertension
and could be reduced by treatment [30]. Angiotensin-
converting enzyme (ACE) inhibitor use was associatedn=109) non-CM (n=196)
ut With p without With P
±15.36 48.76±9.92 0.096 46.41±4.88 52.12±9.66 0.019
.7) 49(89.1) 0.204 104(68.0) 31(73.8) 0.572
8.17 2.12 2.82
±4.53 22.67±3.17 0.957 22.02±3.58 22.54±3.31 0.379
0.227 0.017
.2) 45(81.8) 102(66.7) 36(85.7) 0.378
6.9) 8(14.5) 29(19.0) 6(14.3)
) 2(3.6) 22(14.4) 0
.9) 22(41.5) 0.011 36(23.5) 17(40.5) 0.033
±14.62 78.53±18.13 0.092 77.33±10.86 80.5±12.53 0.141
5±22.98 122.02±28.87 0.040 116.87±16.88 127.57±21.75 0.005
) 5(9.1) 0.561 25(16.3) 6(14.3) 1
1(1.8) 0.527 6(3.9) 2(4.8) 0.545
10.71 17.53±11.78 0.000 6.71±9.37 9.62±8.37 0.057
±8.36 23.09±7.42 0.912 25.73±6.07 25.93±6.21 0.858
1.37 6.81±1.60 0.034 4.88±1.68 5.05±1.79 0.591
.5) 30(55.6) 0.453 36(23.5) 18(43.9) 0.017
.9) 4(7.4) 0.158 11(7.2) 3(7.3) 0.601
algesic >15 days per month, lasted for at least 3 months in recently. Family
tive headache and cerebrovascular disease history; cerebrovascular disease
) et al. P values were two tailed and statistical significance was defined as p
interval) ;SD—standard deviation.BMI—Body Mass Index.
Table 4 The odds ratio of elevated BP frequency in CDH patients with analgesic overuse compared with those without
analgesic overuse
Variable Elevated BP frequency
Total(n) N (%) P Value OR (95% CI)
Compared with those without analgesic overuse
All patients with analgesic overuse 93 39 (41.1) 0.001 2.468 (1.46-4.17)1
CM with analgesic overuse 53 22 (41.5) 0.011 3.265 (1.36-7.83)2
Non-CM with analgesic overuse 42 17 (40.5) 0.033 2.21 (1.075-4.543)3
1 was all CDH patients with analgesic overuse compared with those without, 2 indicated in CM group those with analgesic overuse compared with those without,
3 indicated in non-CM group those with analgesic overuse compared with those without.
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with hypertension [31]. Ziegler et al. found that hyper-
tension had an association with severe headache in
women [32]. Additionally, in major tertiary care centers,
prevalence of hypertension in CDH patients was 16.2%,
which was significantly higher than in those with epi-
sodic migraine and TTH [3]. High BP(CM 33.7% vs. EM
27.9%; OR (95% CI)=1.2 (1.03 to 1.47), p=0.02)) occurred
with greater frequency in CM than in EM[2], in spite of
CM with or without analgesic overuse (OR=2.9/6.9 com-
pared with EM respectively) [5].
In our study, we also found that CDH had a strong as-
sociation with elevated BP (OR (95% CI) = 2.468(1.46–
4.17)). The elevated BP frequency in CDH patients was
27.96%, while the prevalence of hypertension in adults
reached 18.8% in Mainland China in 2002 [33]. Pietrini
et al. evaluated 1486 patients with headache and found
that the prevalence of hypertension was 28%, which was
significantly higher than in all age groups of the general
population [26]. The frequency was similar with our
study.
CM is the most common subtype of CDH [6-9], as in
our study. However, in a study in Taipei, CTTH was the
most common subtype of CDH in older patients [11],
the study included patients aged >65 years, with a mean
age of 73.7 ± 6.9 years, which is older than in the
present and other previous studies. Mathew et al.
reported that CDH patients who transformed from epi-
sodic migraine had a higher likelihood of hypertension
[10]. Bigal et al. showed that prevalence of hypertension
in CM patients was 6.9 times higher than in episodic mi-
graine patients, and 5.1 times higher than in those with
chronic post-traumatic headache [5].
While compared with non-CM, the frequency of ele-
vated BP didn’t increased in CM, there was no signifi-
cantly difference between two groups, although the CM
patient had a longer duration of headache, a more severe
intensity. Maybe there didn’t exist a causal relationship
between the elevated BP frequency and duration of
headache, intensity.
In many studies, analgesic overuse has been identified as
the most important risk factor for CDH and developmentof CM [3,11]. In our study, the occurrence of analgesic
overuse in all CDH patients was 31.3%, 48.6% in CM pa-
tients and 21.5% in non-CM patients; the occurrence of
analgesic overuse in CM was significantly higher than in
non-CM patients. It seems that patients having a longer
duration of headache, more severe pain intensity were
more likely to overused analgesic than patients having a
frequency of headache days /month.
Patients with analgesic overuse had a higher frequency
of elevated BP. Elevated BP was presented in 61.1% of
CDH patients with analgesic overuse. Both In CM and
non-CM groups, the frequency of elevated BP in patients
with analgesic overuse were significantly higher than in
those without analgesic overuse (p<0.05). It seems that
the frequency of elevated BP is associated with analgesic
overuse; maybe there exists a causal relationship be-
tween elevated BP and analgesic overuse.
Acetaminophen and aspirin were the most common
components in our patients with analgesic overuse.
NSAIDs were taken by 8.9% of patients in our previous
study [12], and 7.4% patients had coadministration of
NSAIDs with other analgesics in the present study. Some
studies reported that acetaminophen was linked with a
higher incidence of hypertension [13,14]. Treatment with
acetaminophen resulted in a significant increase in mean
ambulatory SBP in patients with coronary artery disease
[15]. Epidemiological studies such as that by Forman et al.
demonstrated that men who took acetaminophen 6 or 7
d/week had an increased relative risk for hypertension
compared with those taking NSAIDs [34]. Additionally,
in the Nurses’ Health Study I and II, the multivariable-
adjusted relative risk of hypertension in women who
took >500 mg/day acetaminophen was increased almost
2-fold compared with women who did not use acet-
aminophen [16]. Aspirin dose was not significantly
associated with hypertension [16,35]. Low dose aspirin
(75–325 mg/day) use is associated with a significant re-
duction in the risk of cardiovascular events [18,19]. In a
meta-analysis of NSAIDs and acetaminophen, aspirin
use was investigated, although slight increases in BP
were noted, the CIs were wide and not statistically
significant [17].
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have shown that NSAIDs were associated with an
increased risk of hypertension [35,36]. In a recent ana-
lysis of women who provided more extensive data on an-
algesic usage, a significant, dose-dependent increase in
risk of hypertension was observed among those using
NSAIDs irrespective of the reason [16]. In the Physi-
cians’ Health Study, men who estimated taking ≥61
NSAID tablets per year had a RR for hypertension of
1.05 compared with those who took none.
Although both acetaminophen and NSAIDs were
reported elevating BP. In our patients with analgesic
overuse, compound analgesics were the most commonly
used: 96.8% of those who overused analgesics took “anti-
headache flour” or coldrex. The main components of
“Anti-headache flour” were aspirin and acetaminophen.
The main component of coldrex and other compound
analgesic was acetaminophen. Simple analgesics, such as
ibuprofen and naproxen, were usually taken by patients
upon the advice of a doctor, instead of “anti-headache
flour” or coldrex after they had had analgesic overuse.
Few patients took opioids or amitriptyline to alleviate
headache. Almost no patients used ergotamine and
triptans.NSAIDs only accounts for 7.4%. This is similar
to a previous study in Mainland China [12].
In a study in Taipei, 7.5% of patients with analgesic
overuse took ergotamine and caffeine, and 24% to liquid
common cold medications, but overuse of triptans was
rare [37]. In Japan, combination analgesics were a com-
mon choice in patients with analgesic overuse; few pa-
tients took ergotamine and triptans and none overused
opioids [38]. However, in Germany, both ergot alkaloids
and triptans were frequently overused analgesics [39].
Our results suggest that analgesic overuse is the main
reason for patients with CDH having a higher frequency
of elevated BP, and acetaminophen might play an im-
portant role. Pietrini et al. also found that patients with
analgesic overuse had a high prevalence of hypertension
in their headache center (60.6%) [24]. In 2 large, pro-
spective, female cohorts [35,36], an association between
the frequency of analgesic use and risk of developing
hypertension was reported. However, Gipponi et al.
reported that the prevalence of hypertension did not dif-
fer significantly between CDH patients with or without
analgesic overuse [3]. This needs further study.
Low education level plays an important role in CM
with analgesic overuse. In one large cohort of female
health professionals, low socioeconomic status was
associated with an increased frequency of migraine at-
tack [40]. The proportions of patients using prophylactic
medication and having consulted a neurologist were
smaller among those who only had elementary school
education compared with higher education; Those with
a lower level of education also had a higher number ofdays per month with headache and with analgesic
overuse than those with higher educational level [41]. A
multivariate analysis showed that socioeconomic factors
such as having a low level of education and/or a low
household income were associated with analgesic over-
use [42]. Migraine patients with low socioeconomic sta-
tus may have a risk of developing medication overuse
headache, The duration of education was shorter in mi-
graine patients with low income [43]. Low education level
plays an important role in analgesic overuse, so we need
more focus on patients with low education level in future.
Patients with comorbidity of hypertension and mi-
graine have a higher prevalence of cerebrovascular events
[27]. Hypertension amplifies the effect of migraine on the
vascular wall, which further enhances cerebrovascular
endothelial dysfunction [44]. Patients with hypertension
using ACE inhibitors have a significantly lower risk of
headache [32]. Antihypertensive treatment can also de-
crease the incidence of headache [15]. All the above results
emphasize the importance of the control of hypertension
in management of CDH.
The study had some limits. First, this was a cross-
sectional study, BP was evaluated at only one visit; there-
fore, we did not diagnose hypertension, and only defined
the condition of elevated BP. Second, the findings study
was conducted in hospital outpatient; therefore, the results
should not be extrapolated to the general population.
Conclusions
The present study found that CDH patients with analgesic
overuse had a higher frequency of elevated BP than those
without analgesic overuse. Acetaminophen-containing an-
algesics were the most common agents in present study,
which maybe the reason of elevated BP in CDH and its
subtype. These maybes provide basis theory for the hyper-
tension management in CDH, especially in CM.
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